Home > PJ (current issue) > The Society / Daily News | Search

The Pharmaceutical Journal
Vol 273 No 7306 p32
3 July 2004


Society summary


MEP 29th edition gives new practice guidance

The 28th edition of ‘Medicines, ethics and practice: A guide for pharmacists’ has now been published by the Royal Pharmaceutical Society. As well as updating the information in the 27th edition, it includes new practice guidance relating to pharmacy support staff and to supplementary prescribing by pharmacists.

This new information appears in Section 3.3 (Improving the quality of pharmacy practice). A new section 3.3.3 has been added to take account of the Society’s policy on minimum training and competence requirements for pharmacy support staff as from January 2005. It describes the regulatory framework being put into place for pharmacy technicians and sets out the new professional requirements for the training of dispensing/pharmacy assistants as well as the existing requirements relating to the competence of medicines counter assistants.

A new section 3.3.4 summarises the policy framework for supplementary prescribing by pharmacists and the requirements for pharmacists who wish to be registered as supplementary prescribers.

In Part 1 of the guide, which covers general legal requirements, the main changes in the new edition are in Section 1.2 (Medicines for human use), which includes new information on midwives and Controlled Drugs, on NHS prescriptions for the treatment of addicts and on the supply of Controlled Drugs to addicts. In addition, Section 1.4 (Non-medicinal poisons) includes new information relating to the sale or supply of strychnine.

‘Medicines, ethics and practice’ is published by the Society as a day-to-day reference source for practising pharmacists. Copies of the new edition are being sent direct to members with registered addresses in Britain, the Isle of Man and the Channel Islands, other than those who pay the reduced retention fee for members aged over 60 years who are not in gainful employment. Copies are also being sent to preregistration trainees and, in bulk, to all UK schools of pharmacy.

Additional copies are available from the Pharmaceutical Press, Customer Services, PO Box 151, Wallingford, Oxfordshire OX10 8QU (tel 01491 829272; fax 01491 829292; e-mail: rpsgb@cabi.org). Copies may also be ordered online at www.pharmpress.com. The guide costs £12.95, including postage and packing.

The Society’s Fitness to Practise and Legal Affairs Directorate reminds pharmacists that it is a requirement of the Society’s Code of Ethics that the current edition of the guide should be available for consultation in all dispensaries. It says that pharmacists should not rely on information and guidance given in previous editions, which may no longer be accurate.

Given below are the first additions to the list of medicines for human use included in the new edition. Cumulative lists of additions and amendments will be printed in The Journal in the first issue of each month.

Abilify tablets POM
Imigran Radis tablets POM
Levemir preparations POM
Strattera capsules POM
Striant tablets POM

Correction
This news item wrongly referred to an out-of-date Code of Ethics requirement that the current edition of ‘Medicines, ethics and practice: A guide for pharmacists’should be available in all dispensaries.

Back to Top


©The Pharmaceutical Journal